Patient Characteristics | Days of well response | P-value* | Odd’s ratio (95%CI) | |
---|---|---|---|---|
≥ 7 days | < 7 days | |||
Impaired consciousness | ||||
 - Yes | 7 (17.1) | 13 (59.1) | 0.001 | 0.14 (0.04–0.46) |
 - No | 34 (82.9) | 9 (40.9) |  |  |
Convulsion | ||||
 - Yes | 0 | 8 (4.5) | < 0.0001 | 3.93 (2.15–6.18) |
 - No | 41 (100) | 14 (99.5) |  |  |
ARDS | ||||
 - Yes | 19 (46.3) | 3 (13.6) | 0.009 | 5.47 (1.5–21.39) |
 - No | 22 (53.7) | 19 (86.4) |  |  |
Renal failure | ||||
 - Yes | 17 (41.5) | 2 (9.1) | 0.008 | 7.08 (1.46–34.4) |
 - No | 24 (58.5) | 20 (90.9) |  |  |
Jaundice | ||||
 - Yes | 12 (29.3) | 1 (4.5) | 0.021 | 8.69 (1.05–72.1) |
 - No | 29 (70.7) | 21 (95.5) |  |  |
Urine (anuria/oliguria) | ||||
 - Yes | 12 (29.3) | 1 (4.5) | 0.021 | 8.69 (1.05–72.1) |
 - No | 29 (70.7) | 21 (95.5) |  |  |
Splenomegaly | ||||
 - Yes | 9 (22) | 12 (54.5) | 0.009 | 0.23 (0.08–0.72) |
 - No | 32 (78) | 10 (45.5) |  |  |
Complications during treatment | ||||
 - Yes | 25 (61) | 7 (31.8) | 0.027 | 3.35 (1.12–10) |
 - No | 16 (39) | 15 (68.2) |  |  |
 | Required 2ndantimalarial drugs |  | ||
Yes | No | |||
Complications during treatment | ||||
 - Yes | 11 (84.6) | 23 (36.5) | 0.001 | 9.57 (1.95–46.98) |
 - No | 2 (15.4) | 40 (63.5) |  |  |